Katalog der Deutschen Nationalbibliothek

Expertensuche ?

Servicezeiten in Frankfurt am Main ab 1. Dezember 2025: Montag bis Freitag 9–18 Uhr und Samstag 10–16 Uhr
Service hours in Frankfurt am Main from 1 December 2025: Monday to Friday 9:00-18:00 and Saturday 10:00-16:00

Leichte Bedienung, intuitive Suche: Die Betaversion unseres neuen Katalogs ist online! → Zur Betaversion des neuen DNB-Katalogs

Ergebnis der Suche nach: "120960060"
im Bestand: Gesamter Bestand

71 - 80 von 130

	71	AID/APOBEC-network reconstruction identifies pathways associated with survival in ovarian cancer Enthalten in BMC genomics Bd. 17, 16.8.2016, Nr. 1, date:12.2016: 1-28
	72	Aktuelle Therapiestrategien bei malignem Aszites Enthalten in Im Focus Onkologie Bd. 20, 16.12.2017, Nr. 12, date:12.2017: 32-39
	73	Alle Aspekte der Nachsorge in der gynäkologischen Onkologie am Beispiel des Ovarialkarzinoms Enthalten in Journal für gynäkologische Endokrinologie Bd. 31, 1.12.2021, Nr. 4, date:12.2021: 129-135
	74	Ambivalent role of pFAK-Y397 in serous ovarian cancer-a study of the OVCAD consortium Enthalten in Molecular cancer Bd. 13, 21.3.2014, Nr. 1, date:12.2014: 1-11
	75	An intracellular targeted antibody detects EGFR as an independent prognostic factor in ovarian carcinomas Enthalten in BMC cancer Bd. 11, 14.7.2011, Nr. 1, date:12.2011: 1-8
	76	ASO Visual Abstract: Impact of BRCA Mutation Status on Tumor Dissemination Pattern, Surgical Outcome, and Patient Survival in Primary and Recurrent High-Grade Serous Ovarian Cancer (HGSOC). A Multicenter, Retrospective Study of the Ovarian Cancer Therapy—Innovative Models Prolong Survival (OCTIPS) Consortium Enthalten in Annals of surgical oncology Bd. 30, 5.11.2022, Nr. 1, date:1.2023: 46-47
	77	Assessment of a six gene panel for the molecular detection of circulating tumor cells in the blood of female cancer patients Enthalten in BMC cancer Bd. 10, 3.12.2010, Nr. 1, date:12.2010: 1-12
	78	Catumaxomab with and without prednisolone premedication for the treatment of malignant ascites due to epithelial cancer: results of the randomised phase IIIb CASIMAS study Enthalten in Medical oncology Bd. 31, 26.6.2014, Nr. 8, date:8.2014: 1-10
	79	Characterisation of homologous recombination deficiency in paired primary and recurrent high-grade serous ovarian cancer Enthalten in British journal of cancer Bd. 119, 15.10.2018, Nr. 9, date:10.2018: 1060-1066
	80	Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study) Enthalten in British journal of cancer Bd. 119, 29.6.2018, Nr. 3, date:8.2018: 330-338

71 - 80 von 130

Alle Materialarten > Artikel (130)

Alle Standorte

Aktionen

Administration